Harrow Health Announces Closing of $50 Million Offering of Senior Notes Due 2026
April 20, 2021 16:01 ET
|
Harrow Health, Inc.
NASHVILLE, Tenn., April 20, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) (“Harrow Health” or the “Company”), an ophthalmic-focused healthcare company, today announced the closing of...
Adverum Biotechnologies to Present New Data from the OPTIC Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at ARVO 2021
April 16, 2021 08:05 ET
|
Adverum Biotechnologies, Inc.
-- Adverum to host webcast with key opinion leaders on Sunday, May 2, 2021 at 7:00 AM PT -- REDWOOD CITY, Calif., April 16, 2021 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM),...
ProQR Announces Publication in Nature Medicine for Sepofarsen in Leber Congenital Amaurosis 10
April 13, 2021 16:15 ET
|
ProQR Therapeutics N.V.
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 13, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA...
ForeseeHome AMD home monitoring real-world data analysis demonstrates substantial benefit for patients’ vision
April 06, 2021 08:00 ET
|
Notal Vision
Manassas, VA, April 06, 2021 (GLOBE NEWSWIRE) -- Real-world data on the performance of the ForeseeHome® AMD Monitoring Program, a home-based diagnostic that helps detect the conversion from...
ProQR Announces Closing of Underwritten Public Offering of Ordinary Shares with Full Exercise of Underwriters’ Option to Purchase Additional Shares
April 05, 2021 16:15 ET
|
ProQR Therapeutics N.V.
LEIDEN, Netherlands and CAMBRIDGE, Mass., April 05, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR), a company dedicated to changing lives through the creation of transformative...
Tarsus Pharmaceuticals, Inc. Reports Full-Year 2020 Financial Results and Business and Clinical Updates
March 31, 2021 16:05 ET
|
Tarsus Pharmaceuticals, Inc
Enrollment complete for Saturn-1, first TP-03 pivotal trial for the treatment of Demodex blepharitis; initiation of Saturn-2 expected in Q2 2021 Strategic partnership with LianBio in March 2021 for...
Tarsus Pharmaceuticals and LianBio Announce Strategic Partnership to Develop and Commercialize TP-03 in Greater China for the Treatment of Demodex Blepharitis and Meibomian Gland Disease
March 29, 2021 16:05 ET
|
Tarsus Pharmaceuticals, Inc
IRVINE, Calif., SHANGHAI, China and PRINCETON, N.J., March 29, 2021 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company, and LianBio, a...
Visionary Ventures Closes Fund II with $114MM in Committed Capital
March 23, 2021 09:17 ET
|
Visionary Venture Fund
Aliso Viejo, California, March 23, 2021 (GLOBE NEWSWIRE) -- Visionary Ventures today announced the closing of Visionary Venture Fund II with $114MM in committed capital. The Fund, which was strongly...
Nextech Announces Registration Launch For Virtual User Conference: Edge 2021
March 17, 2021 11:44 ET
|
Nextech Systems, Inc.
TAMPA, Fla., March 17, 2021 (GLOBE NEWSWIRE) -- Nextech Systems, a leading provider of healthcare technology solutions for specialty physician practices, today opened registration for its seventh...
Ophthalmology Market Value Anticipated To Reach US$ 64.3 Billion By 2027: Acumen Research And Consulting
March 17, 2021 11:35 ET
|
Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Ophthalmology Market– Global Industry Analysis, Market Size, Opportunities and...